logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
E

Edurne Arriola

institut hospital del mar d’investigacions mèdiques
H指数:35
被引数:3,813

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immune checkpoint inhibitor-related myocarditis, myositis, and myasthenia gravis overlap syndrome: a single-center case series and systematic review

免疫检查点抑制剂相关心肌炎、肌炎和重症肌无力重叠综合征：单中心病例系列和系统综述

Supportive Care in Cancer
IF3
2026-10-150
PRE
Jorge Soriano; Miguel Martínez-Rubiño; Miren Vicente Elcano; Martina Pellicer Pérez; Arantxa  Bergua de Roque; Sofia Tanco Mulero; Claudia Miquel Bosh; Ana Chen-Ye; Deborah Martín Ruiz; Ines Torras-Vigo; Andres Pellicer-Boiges; Mireia Ble Gimeno; Nil Navarro-Gorro; Laia Carla Belarte-Tornero; Laura Visa; Álvaro Taus; Jose Enrique Rodriguez Martínez; Alejo Rodriguez-Vida; Edurne Arriola; Mariona Llaberia-Torrelles
Soluble Immune Checkpoints as Prognostic Biomarkers in Small Cell Lung Cancer Patients Treated with Chemotherapy and Anti-PD-L1

可溶性免疫检查点作为接受化疗和抗PD-L1治疗的小细胞肺癌患者的预后生物标志物

International Journal of Molecular Sciences
IF4.9
2026-08-120
OA
Albert Guinart-Cuadra; Aida Piedra; Sergio Martínez-Recio; Maria Mulet; Carlos Zamora; Rubén Osuna-Gómez; Elisabet Cantó; Maria Angels Ortiz; Andrés Barba; Judit Sanz-Beltran; Jorgina Serra-López; Luís Paz-Ares; Edurne Arriola; Alberto Luis Moreno; Rosario Garcia-Campelo; Cristina Martí-Blanco; Dolores Isla; Ángel Callejo; Margarita Majem; Silvia Vidal
Clinical outcomes of KRAS G12C versus non-G12C mutant NSCLC treated with immunotherapy: a multicentre real-world study

免疫疗法治疗KRAS G12C突变与非G12C突变非小细胞肺癌的临床结局：一项多中心真实世界研究

Lung Cancer
IF4.4
2026-08-070
OAAI
Laura Masfarré; Ana Sofia Parreira; Natalia Castro; Claudia Miquel; Nil Navarro-Gorro; Raquel Marse Fabregat; Cristina Gomez Bellvert; Amaia Ariño Fernandez; Antonia Company Serra; Maite Martinez Aguillo; Hugo Arasanz; Lucia Teijeira; Idoia Morilla; Pedro Rocha; Miguel Galindo; Sergi Clave; Alvaro Taus; Aitor Azkarate Martinez; Edurne Arriola
Osimertinib after definitive CRT in unresectable stage III EGFR-mutated NSCLC: safety outcomes from the phase III LAURA study

奥希替尼在不可切除III期EGFR突变非小细胞肺癌中序贯根治性放化疗后的安全性结局：III期LAURA研究

Lung Cancer
IF4.4
2026-06-060
PREAI
Terufumi Kato; Xiaorong Dong; Toshiaki Takahashi; Nopadol Soparattanapaisarn; Sarayut Lucien Geater; Chih-Liang Wang; Edurne Arriola; Fedor Moiseenko; Lucy Thompson; Ellie Grainger; Elena Armenteros-Monterroso; Azura Evans; Ana Bolanos; Suresh S. Ramalingam; Shun Lu
Brief report: Artificial intelligence meets small cell lung cancer—integrating clinicopathological and wholeslide image data for prognostic prediction in SCLC

简要报告: 人工智能与小细胞肺癌相遇-整合临床病理和整体影像数据以预测SCLC的预后

Frontiers in Artificial Intelligence
IF4.7
2026-04-200
OA
PR Pedro Rocha †; JG Joan Gibert †; SM Silvía Menendez; RD Raúl del Rey-Vergara; AI Albert Iñañez; LM Laura Masfarré; NN Nil Navarro; AR Alejandro Ríos-Hoyo; SP Sandra Perez; ÁT Álvaro Taus; MG Mario Giner; AR Ana Rovira; LL Luis León-Mateos; DI Dolores Isla; LP Luis Paz-Ares; JZ Jon Zugazagoitia; CM Cristina Martí Blanco; RG Rosario García-Campelo; AM Alberto Moreno-Vega; ÁC Ángel Callejo; FR Federico Rojo; IS Ignacio Sanchéz; EA Edurne Arriola
Baseline PD-L1 expression on circulating immune cells as a predictor of survival and immune-related adverse events in extensive-stage small-cell lung cancer patients treated with durvalumab and carboplatin-etoposide (NCT04712903 Trial)

基线时循环免疫细胞中PD-L1的表达作为接受度鲁鲁单抗联合卡铂-足叶乙苷治疗广泛期小细胞肺癌患者生存和免疫相关不良事件的预测因子（NCT04712903试验）

Journal of Translational Medicine
IF7.5
2026-02-280
OAAI
Aida Piedra; Albert Guinart-Cuadra; Sergio Martínez-Recio; Maria Mulet; Carlos Zamora; Rubén Osuna-Gómez; Elisabet Cantó; Maria Angels Ortiz; José Alejandre; Andrés Barba; Judit Sanz-Beltrán; Jorgina Serra-López; Dolores Isla; Edurne Arriola; Luis Paz-Ares; María Pilar Diz-Taín; Alberto Luis Moreno; Ángel Callejo; Silvia Vidal; Margarita Majem
Corrigendum to ”Characterization and economic burden of KRASG12C-mutant lung cancer in real-world Spanish practice: a retrospective observational study (SILK study)” [Lung Cancer 206 (2025) 108677]

勘误：“KRASG12C突变型肺癌在西班牙真实世界实践中的特征和经济负担：一项回顾性观察性研究（SILK研究）”[肺癌 206 (2025) 108677]

Lung Cancer
IF4.4
2025-10-080
OAAI
Noemí Reguart; Laura Sampietro-Colom; Òscar Juan-Vidal; Mònica Aguiló; Edurne Arriola; Joan Sánchez; Carla Fernández-Barceló; Ismail Abbas; Carlos López; Xavier Botella; Francesc Cots; Cristina Teixido; Daniel Martínez; Sarai Palanca; Emma Borràs; Laura Masfarré; Cristina Siles Cuesta; Maria Eugenia Gas Lopez; Laura Planellas; Ariadna Lloansí
Durvalumab plus platinum-etoposide in the first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): A single-arm clinical trial

度伐利尤单抗联合铂类-依托泊苷在广泛期小细胞肺癌一线治疗中的应用（CANTABRICO）：一项单臂临床试验

Lung Cancer
IF4.4
2025-09-240
PRE
Dolores Isla; Jon Zugazagoitia; Edurne Arriola; Rosario García-Campelo; Cristina Martí Blanco; María Pilar Diz-Taín; Marta López-Brea; Alberto Luis Moreno-Vega; Luis León-Mateos; Juana Oramás; Vanesa Gutiérrez-Calderón; Margarita Majem; Alfredo Sánchez-Hernández; Carlos Aguado; Ruth Alvarez-Cabellos; Bartomeu Massutí; Amaia Moreno; José-Luis Fírvida-Pérez; Javier Valdivia; Marta González-Cordero; Marta Zafra-Poves; Manuel Dómine; Francisco Javier Garcia-Navalon; Noemí Villanueva; Mariano Provencio; Oscar Juan-Vidal; Carlos Rivas-Corredor; María Eugenia Olmedo García; Ramón Palmero; Rafael López-Castro; Enric Carcereny; José Luis Lechuga; Marta Domínguez; Ángel Callejo; Luis Paz-Ares
Characterization and economic burden of KRASG12C-mutant lung cancer in real-world Spanish practice: a retrospective observational study (SILK study)

KRASG12C突变型肺癌在西班牙真实世界实践中的特征及经济负担：一项回顾性观察性研究（SILK研究）

Lung Cancer
IF4.4
2025-07-220
PRE
Noemí Reguart; Laura Sampietro-Colom; Òscar Juan-Vidal; Mònica Aguiló; Edurne Arriola; Joan Sánchez; Carla Fernández-Barceló; Ismail Abbas; Carlos López; Xavier Botella; Francesc Cots; Cristina Teixido; Daniel Martínez; Sarai Palanca; Emma Borràs; Laura Masfarré; Cristina Siles Cuesta; Maria Eugenia Gas Lopez; Laura Planellas; Ariadna Lloansí
MET pathway inhibition increases chemo-immunotherapy efficacy in small cell lung cancer

MET通路抑制可增强小细胞肺癌的化疗-免疫治疗疗效

Cell Reports Medicine
IF10.6
2025-06-200
OAAI
Raúl del Rey-Vergara; Miguel Alejandro Galindo-Campos; Pedro Rocha; Marina Carpes; Carlos Martínez; Laura Masfarré; Silvia Menéndez; Fabricio Quimis; Adrià Rossell; Albert Iñañez; Sandra Pérez-Buira; Federico Rojo; Ramon Gimeno; Dolores Isla; Jon Zugazagoitia; Cristina Martí Blanco; Rosario García-Campelo; Alberto Moreno-Vega; Luis León-Mateos; Ángel Callejo Mellén; Kwon-Sik Park; Simon Heeke; John V. Heymach; Álvaro Taus; Luis Paz-Ares; Ana Rovira; Edurne Arriola
Prevalence of EGFR gene mutations in patients with early-stage resectable non-small cell lung cancer in Spain: the ORIGEN study

西班牙早期可切除非小细胞肺癌患者中EGFR基因突变的发生率：ORIGEN研究

TRANSLATIONAL LUNG CANCER RESEARCH
IF3.5
2025-04-010
OA
Varela, Mar; Teixido, Cristina; Alvarez-Fernandez, Carlos; Arasanz, Hugo; Peralta, Sergio; Lazaro, Martin; Calvo, Virginia; Alvarez, Rosa; Baena, Javier; Valdivia, Javier; Arriola, Edurne; Bernabe, Reyes; Isla, Dolores; Camacho, Carmen; Massuti, Bartomeu; Blasco, Ana; Garcia, Teresa; Cobo, Manuel; Campayo, Marc; Hijazo-Pechero, Sara; Callejo, Angel; Dominguez, Marta
DNA damage response signatures are associated with frontline chemotherapy response and routes of tumor evolution in extensive stage small cell lung cancer

DNA损伤应答特征与广泛期小细胞肺癌的一线化疗反应及肿瘤进化途径相关。

MOLECULAR CANCER
IF33.9
2025-03-200
OA
Morris, Benjamin B.; Heeke, Simon; Xi, Yuanxin; Diao, Lixia; Wang, Qi; Rocha, Pedro; Arriola, Edurne; Lee, Myung Chang; Tyson, Darren R.; Concannon, Kyle; Ramkumar, Kavya; Stewart, C. Allison; Cardnell, Robert J.; Wang, Runsheng; Quaranta, Vito; Wang, Jing; Heymach, John V.; Nabet, Barzin Y.; Shames, David S.; Gay, Carl M.; Byers, Lauren A.
Molecular and immunological features associated with long-term benefits in metastatic NSCLC patients undergoing immune checkpoint blockade

接受免疫检查点阻断的转移性NSCLC患者的分子和免疫学特征与长期获益相关

ONCOIMMUNOLOGY
IF6.3
2025-02-240
OA
Rocha, Pedro; Bach, Rafael; Masfarre, Laura; Hernandez, Sharia; Navarro-Gorro, Nil; Rossell, Adria; Villanueva, Xavier; Giner, Mario; Sanchez, Ignacio; Galindo, Miguel; Del Rey-Vergara, Raul; Inanez, Albert; Sanchez-Espiridion, Beatriz; Lu, Wei; Acedo-Terrades, Ariadna; Berenguer-Molins, Pau; Sanchez-Font, Albert; Chalela, Roberto; Curull, Victor; Taus, Alvaro; Hardy-Werbin, Max; Sausen, Mark; Georgiadis, Andrew; White, James; Jackson, Jennifer B.; Moliner, Laura; Clave, Sergi; Bellosillo, Beatriz; Rovira, Ana; Wistuba, Ignacio; Soto, Luisa M. Solis; Perera-Bel, Julia; Arriola, Edurne
First-line pembrolizumab in patients with advanced non-small cell lung cancer and high PD-L1 expression: real-world data from a Spanish multicenter study
FRONTIERS IN ONCOLOGY
IF3.3
2024-12-170
OAAI
Piedra, Aida; Martinez-Recio, Sergio; Hernandez, Ainhoa; Moran, Teresa; Arriola, Edurne; Recuero-Borau, Jordi; Cobo, Manuel; Cordeiro, Patricia; Mosquera, Joaquin; Fernandez, Manuel; Garcia-Campelo, Rosario; Calles, Antonio; Alvarez, Rosa; Zapata-Garcia, Maria; Isla, Dolores; Callejo, Ana; Iranzo, Patricia; Serra-Lopez, Jorgina; Barba, Andres; Sullivan, Ivana; Felip, Enriqueta; Majem, Margarita
Molecular characterization from IMfirst: Atezolizumab plus chemotherapy in extensive-stage small cell lung cancer (ES-SCLC) in Spain

IMfirst研究中的分子特征分析：阿特珠单抗联合化疗治疗西班牙广泛期小细胞肺癌（ES-SCLC）

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Cobo Dols, M.; Domine Gomez, M.; de Castro Carpeno, J.; Moreno Vega, A. L.; Ponce Aix, S.; Arriola Aperribay, E.; Carcereny, E.; Majem, M.; Huidobro Vence, G.; Esteban Gonzalez, E.; Fuentes Pradera, J.; Ortega Granados, A. L. O.; Guillot Morales, M.; Massuti Sureda, B.; Lianes Barragan, P.; Gonzalez Mancha, N.; Fajardo, C. A.; Garcia Palacios, L.; Lerones Laborda, N.; Garcia Campelo, M. R.
Association between baseline PD-L1 expression in circulating leukocytes, the presence of immune-related adverse events (irAEs) and survival outcomes in patients with extensive-stage small-cell lung cancer (ES-SCLC) from the CANTABRICO trial

循环白细胞中基线PD-L1表达、免疫相关不良事件(irAEs)的发生以及广泛期小细胞肺癌(ES-SCLC)患者生存结局之间的关联：来自CANTABRICO试验的数据

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Piedra, A.; Guinart-Cuadra, A.; Mulet, M.; Zamora, C.; Alejandre, J.; Martinez Recio, S.; Barba Joaquin, A.; Sullivan, I. G.; Serra Lopez, J.; Isla Casado, M. D.; Arriola Aperribay, E.; Paz-Ares, L. G.; Diz Tain, P.; Moreno Vega, A. L.; Callejo, A.; Vidal, S.; Majem, M.
RET Fusion Testing in Patients With NSCLC: The RETING Study
JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2024-04-012
OA
Conde, Esther; Hernandez, Susana; Carrillo, Jose Luis Rodriguez; Martinez, Rebeca; Alonso, Marta; Curto, Daniel; Jimenez, Beatriz; Caminoa, Alejandra; Benito, Amparo; Garrido, Pilar; Clave, Sergi; Arriola, Edurne; Esteban-Rodriguez, Isabel; De Castro, Javier; Sansano, Irene; Felip, Enriqueta; Rojo, Federico; Domine, Manuel; Abdulkader, Ihab; Garcia-Gonzalez, Jorge; Teixido, Cristina; Reguart, Noemi; Compan, Desamparados; Insa, Amelia; Mancheno, Nuria; Palanca, Sarai; Juan-Vidal, Oscar; Baixeras, Nuria; Nadal, Ernest; Cebollero, Maria; Calles, Antonio; Martin, Paloma; Salas, Clara; Provencio, Mariano; Aranda, Ignacio; Massuti, Bartomeu; Lopez-Vilaro, Laura; Majem, Margarita; Paz-Ares, Luis; Lopez-Rios, Fernando

研究方向

暂未获取到该数据
Á
Álvaro Taus
H 指数:25论文数:150被引数:1,814
P
Pedro Rocha
H 指数:18论文数:131被引数:1,153
S
Sergi Clavé
H 指数:13论文数:61被引数:517
M
Margarita Majem
H 指数:55论文数:536被引数:2.4万
M
Max Hardy-Werbin
H 指数:9论文数:43被引数:403
A
Ana Rovira
H 指数:44论文数:378被引数:6,781
B
Beatríz Bellosillo
H 指数:57论文数:542被引数:1.4万
D
Dolores Isla
H 指数:43论文数:355被引数:1.9万
M
Marta Salido
H 指数:38论文数:257被引数:4,824
M
Moliner, Laura
H 指数:0论文数:1被引数:10